Homosexuals report more problems with prostate cancer drug than heterosexuals, study finds

Researchers compared heterosexual and homosexual men receiving a 50mg daily dose of bicalutamide, a fast-acting, non-steroidal anti-androgen, which is similar to other anti-androgens, but with reportedly fewer side effects. They discovered that homosexual men reported that their sexual performance and satisfaction more than halved in four of the six categories studied. Heterosexual men, on the other hand, reported fewer problems and were considerably more satisfied with intercourse.

Read the whole article on Science Daily

More from Science Daily